Kathryn Jean Boor Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Kathryn Jean Boor is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 5,880 shares of SRPT, which is worth approximately $714,420. The most recent transaction as insider was on Dec 05, 2024, when has been sold 1,636 shares (Common Stock) at a price of $125.55 per share, resulting in proceeds of $205,399. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.88K

21.77% 3M change

8.57% 12M change

Total Value Held $714,420

Kathryn Jean Boor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 05 2024	SELL Open market or private sale	$205,399 $125.55 p/Share	1,636 Reduced 21.77%	5,880 Common Stock
Mar 11 2024	SELL Open market or private sale	$93,549 $122.93 p/Share	761 Reduced 9.19%	7,516 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	1,846 Added 18.24%	8,277 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	1,523 Added 19.15%	6,431 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	4,908 Added 50.0%	4,908 Common Stock

Also insider at

IFF

INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials

Director

KJB